Marinomed Biotech AG
F:93Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Marinomed Biotech AG
F:93Z
|
AT |
|
Sixty North Gold Mining Ltd
F:2F40
|
CA |
|
R
|
Rivalry Corp
F:9VK
|
CA |
|
XTI Aerospace Inc
NASDAQ:XTIA
|
US |
Intrinsic Value
Is 93Z undervalued or overvalued?
See the intrinsic value estimate for Marinomed Biotech AG and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
93Z looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with 93Z’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Marinomed Biotech Does
Marinomed Biotech AG is an Austrian specialty biotech company that develops and sells medicines and medical products for respiratory and eye conditions. Its best-known products are based on two technology platforms: Carragelose, a seaweed-derived antiviral ingredient used in nasal sprays and throat products, and Marinosolv, a formulation technology designed to make hard-to-dissolve drug compounds easier to use in eye and allergy treatments.
- Headquarters
- Austria AT
- Employees
- 32
- IPO date
- Feb 1, 2019
Earnings Waterfall
Marinomed Biotech AG
The intrinsic value for Marinomed Biotech AG (93Z) under the Base Case is hidden EUR.
Compared with the current market price of 3.76 EUR, the stock appears hidden.